Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Fostamatinib

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Artax Achieves Clinical Validation of AX-158 for Autoimmune Disease
    Artax Achieves Clinical Validation of AX-158 for Autoimmune Disease

    22 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/artax-biopharma-achieves-clinical-validation-of-first-in-class-oral-nck-modulator-ax-158-for-autoimmune-disease-in-phase-2a-study-302356945.html

    PR NEWSWIRE
    22 Jan 2025
    Share Share
    Rigel’s Fostamatinib Studied in NIH With Sickle Cell Disease
    Rigel’s Fostamatinib Studied in NIH With Sickle Cell Disease

    22 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rigels-fostamatinib-being-studied-by-national-institute-of-health-in-patients-with-sickle-cell-disease-302356919.html

    PR NEWSWIRE
    22 Jan 2025
    Share Share
    Mitsubishi Tanabe Signs Fostamatinib License With Kissei Taiwan
    Mitsubishi Tanabe Signs Fostamatinib License With Kissei Taiwan

    09 Jan 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/mitsubishi-tanabe-pharma-enters-into-a-sub-licensing-agreement-for-oral-spleen-tyrosine-inhibitor-fostamatinib-in-taiwan-with-kissei-pharmaceutical-16644

    INDPHARMAPOST
    09 Jan 2025
    Share Share
    Optime Care Expands Partnership With Rigel For Tavalisse Distribution
    Optime Care Expands Partnership With Rigel For Tavalisse Distribution

    16 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/16/2964215/0/en/Optime-Care-Expands-Partnership-with-Rigel-Pharmaceuticals-to-Include-Commercial-Distribution-for-TAVALISSE.html

    GLOBENEWSWIRE
    16 Oct 2024
    Share Share
    Annora Pharma`s Generics Fostamatinib Receives Approval in US
    Annora Pharma`s Generics Fostamatinib Receives Approval in US

    23 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217329

    FDA
    23 Sep 2024
    Share Share
    Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update
    Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update

    06 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rigel-reports-second-quarter-2024-financial-results-and-provides-business-update-302215852.html

    PR NEWSWIRE
    06 Aug 2024
    Share Share